Tumor proliferation was measured by immunohistochemical staining of Ki67, which resulted in 5-fold decrease of Ki67 positive cells in the triple combination group while about 40% increase of Ki67 positive cells in the irinotecan group (Fig. 5d). Here, MKI67 is linked to neoplasm.